Neuromodulatory systems are essential for remodeling glutamatergic connectivity during experience-dependent cortical plasticity. This permissive/enabling function of neuromodulators has been associated with their capacity to facilitate the induction of Hebbian forms of long-term potentiation (LTP) and depression (LTD) by affecting cellular and network excitability. In vitro studies indicate that neuromodulators can also affect the expression of Hebbian plasticity in a pull-push manner: receptors coupled to the G-protein Gs promote the expression of LTP at the expense of LTD, and Gq-coupled receptors promote LTD at the expense of LTD. Here we show that the pull-push mechanism can be recruited in vivo by pairing brief monocular stimulation with pharmacological or chemogenetical activation of Gs-or Gq-coupled receptors to respectively enhance or reduce visual cortical responses. These changes were stable, can be induced in adults after the termination of the critical period for juvenile ocular dominance plasticity, and can rescue deficits induced by prolonged monocular deprivation.
INTRODUCTION
Sensory experience can shape cortical circuitry and function. One clear demonstration of this is seen the visual cortex during a postnatal critical period, when brief visual deprivation in one eye can reduce the cortical responsiveness to the deprived eye while increasing the responsiveness to the fellow eye (for recent reviews see Espinosa and Stryker, 2012; Hensch and Quinlan, 2018) . It has been widely recognized that this type of neural plasticity requires Hebbian-like forms of long-term potentiation (LTP) and depression (LTD) and neuromodulatory signals conveying information on the organism's behavioral state (for reviews see Gu, 2002 Gu, , 2003 Hofer et al., 2006; Kasamatsu, 1991; Smith et al., 2009) . How neuromodulators and Hebbian plasticity interact during cortical remodeling, however, is not fully understood.
Studies in vitro have demonstrated that neuromodulators can gate the induction of Hebbian plasticity by promoting excitability in cortical circuits (for reviews see Brzosko et al., 2019; Foncelle et al., 2018; Frémaux and Gerstner, 2015; Palacios-Filardo and Mellor, 2019; Pawlak et al., 2010) . In addition, neuromodulators can also control the expression of synaptic plasticity, affecting its gain and polarity. These effects on the expression of synaptic plasticity result from the activation of distinct G-protein coupled receptors (GPCRs). A picture emerging from studies in the visual cortex is a simple rule in which Gs-coupled receptors that activate the adenylyl cyclase pathway and Gq-coupled receptors that activate the phospholipase-C (PLC) pathway have opposite effects on LTP and LTD (Huang et al., 2010; Seol et al., 2007) . Gscoupled promote LTP and suppress LTD, whereas Gq-coupled receptors promote LTD and suppress LTP. An attractive consequence of the pull-push rule is the wide range of possible outcomes, from and LTP-only state when activity of Gs dominates, to an LTD-only state when Gq dominates (Huang et al., 2010 (Huang et al., , 2012 (Huang et al., , 2013 . Thus, the pull-push neuromodulation of LTP/D by the balance of Gs/Gq activity could serve as a metaplasticity mechanism allowing a rapid reconfiguration of the plastic state of cortical synapses.
Motivated by the considerations above we examined whether GPCRs can shape experience-dependent plasticity in mouse V1 in vivo via a pull-push mechanism. Our results show that targeting receptors coupled to Gs or Gq in conjunction with visual stimulation can increase or decrease cortical response in a manner consistent with the pull-push model. These cortical changes were robust, stable in the absence of further visual conditioning, could be induced in adults long after the termination of the critical period for ocular dominance plasticity and can reverse ocular dominance imbalance induced by prolonged monocular deprivation.
RESULTS
We evaluated the pull-push neuromodulation of plasticity in vivo in the mouse visual cortex. We asked whether combining monocular stimulation or deprivation with the manipulation of GPCRs affects visual cortical responses in a manner predicted by the pull-push model, that is Gq-coupled receptors promoting depression and Gs-coupled receptors promoting potentiation. Changes in visual responses were monitored with optical imaging of intrinsic signal in V1 (Kalatsky and Stryker, 2003) , and GPCRs were specifically targeted with pharmacology and chemogenetics (see methods).
Systemic administration of GPCR agonists in conjunction with brief monocular visual conditioning induces bidirectional change of ocular dominance
We first tested whether brief monocular stimulation paired with activation of 5HT2c serotonergic receptors (paired to Gq) induces lasting depression of the visual responses, and whether the same visual stimulation, but paired with the activation of b-adrenergic receptors (bAR, coupled to Gs) potentiates the visual responses in juvenile mice (4 to 5-week old). We choose these particular receptors because in monocular deprivation, the disconnection of the deprived eye requires serotonin, while the potentiation of the fellow eye requires norepinephrine (Nakadate et al., 2013) . In addition, bAR and 5HT2c are unique in supporting LTP and LTD, respectively, evoked with reinforcement like approaches (He et al., 2015) .
The experimental schedule is depicted in Figure 1A . On the first day the cortical responses to either eye was measured in the binocular segment of V1 in one hemisphere. Next day the dominant eye (contralateral to the imaged hemisphere) was conditioned under isoflurane anesthesia with visual stimulation (1 hour. See methods for more details) in conjunction with systemic injection of one specific agonists (bAR: isoproterenol, 15 mg/kg, i.p.; 5-HT2c: Ro 60-0175, 10 mg/kg, i.p.). Following the visual conditioning, the mice were immediately brought into the dark to prevent visual experience until a later imaging session the following day.
In naïve mice the contralateral eye dominates the visual cortical response in the binocular zone, and the computed ocular dominance index is typically about 0.3 (see methods).
In a first round of experiments we conditioned the contralateral eye in the presence of Ro 60-0175, the agonist for the Gq-coupled receptor 5-HT2C. As shown in Figure 1B ,C and in accordance with the role of Gq-coupled receptors in synaptic LTD, this conditioning specifically depressed the contralateral responses (before: 2.38±0.23, after: 1.84±0.21, p=0.037) without affecting the ipsilateral responses (before: 1. 29±0.11, after: 1.27±0.13, p=0.75, n=10) , which translated in a significant decrease in the ODI magnitude (ODI, before: 0.28±0.02, after: 0.14±0.02, p=0.002, n=10). In a similar fashion, visual conditioning paired with injection of an agonist for another Gq-coupled receptor (methoxamine:15 mg/kg, i.p., the α1-adrenergic receptor agonist), also lowered the ODI magnitude compared to those of the vehicle control group (ODI, methoxamine: 0.10±0.04, n=5; vehicle: 0.27±0.02, n=7, Wilcoxon rank sum test, p=0.001; Supplementary Figure 1B ). On the other hand, the same visual conditioning, but in the presence of isoproterenol, the agonist for Gs-coupled bAR, resulted in the opposite outcome in both the ODI and the response amplitude of the conditioned eye. The ODI increased after the visual conditioning, mainly by the potentiation of the conditioned eye, as the response amplitude from the other eye was not changed (response amplitude from conditioned eye, before: 2.74±0.15, after: 3.52±0.28, p=0.019; non-conditioned eye, before: 1.55±0.09, after: 1.65±0.12, p=0.344; ODI, before: 0.26±0.02, after: 0.36±0.03, p=0.011, n=9; Figure 1D and 1E).
As controls, we confirmed that the monocular visual conditioning alone did not induce significant changes in the ODI as well as the response amplitude (response amplitude from conditioned eye, before: 2.43±0.16, after: 2.62±0.39, p=1; from non-conditioned eye, before: 1.36±0.11, after: 1.50±0.24, p=0.687; ODI, before: 0.26±0.02, after: 0.27±0.02, p=1; n=7) ( Figure 1F and 1G ). In addition, the agonists alone (without any visual stimulus) did not affect the responses and the ODI (ODI; naïve: 0.26±0.01, n=26; isoproterenol: 0.27±0.02, n=7; Ro 60-0175: 0.26±0.03, n=6; methoxamine: 0.26±0.01, n=6; F3,41 = 0.09, p=0.964) ( Supplementary   Figure 1 ). Altogether the results indicate that activation of GPCR signals can promote rapid and persistent bidirectional changes in ocular dominance. Importantly, the polarity of the changes is consistent with the pull-push model, with Gq-coupled receptors promoting depression, and Gscoupled receptors promoting potentiation. Also, worth noting, only 1 hour of conditioning with neuromodulator induced changes in ODI of comparable magnitude of those induced by several days of monocular deprivation (Cang et al., 2005; Sato and Stryker, 2008) 
Activation of Gq-or Gs-coupled DREADD promotes pull-push neuromodulation
The systemic administration of agonists can stimulate receptors outside the visual cortex, and potentially outside the nervous system, complicating the interpretation of the results. To confirm the role of the cortex in the changes described above, we employed a chemogenetic approach and virally transfected the visual cortex to express designer receptors exclusively activated by designer drugs (DREADDs). Thus, the systemic administration of the DREADDs agonist will only affect the targeted region. In the case of Gq-DREADDs we injected an adenoassociated virus (AAVs) containing neuronal DREADDs gene; in the case of Gs-DREADDs we used Gs-DREADDs knock-in mice (Akhmedov et al., 2017) injected with AAVs containing panneuronal Cre recombinase gene (rAAV-hSyn-Cre) (see methods for more details).
First, we examined if the Gq-and Gs-DREADDs can promote LTD and LTP in a pull-push manner as the endogenous GPCRs do (Huang et al., 2012; Seol et al., 2007) . The assessment was done in visual cortical slices, in layer 2/3 pyramidal cells expressing Gq-and Gs-DREADDs. We used a spike-timing dependent plasticity (STDP) protocol ( Supplementary Figure 2A Altogether, the results above validated the use of DREADDs. Therefore, to ascertain the role of cortex in the pull-push neuromodulation of ODP, we tested if the systemic injection of CNO (10 mg/kg, i.p.) in conjunction with monocular stimulation can promote bidirectional change of ocular dominance in mice expressing Gq-or Gs-DREADDs in vivo. As depicted in Figure 2A , the experimental schedule was very similar to the one use for the agonist for endogenous GPCR. The results were similar to that obtained with pharmacology. Monocular stimulation of mice expressing Gq-DREADDS in V1 in conjunction with systemic injection of CNO significantly reduced the ODI in the contralateral binocular cortex (ODI, before: 0.21±0.01, after: 0.06±0.03, p=0.031, n=6; Figure 2B and 2C). The injection of CNO alone in the dark did not change the ODI (ODI, before: 0.32±0.04, after: 0.31±0.03, p=0.875, n=4). On the other hand, in the mice expressing the Gs-DREADDs monocular conditioning caused a lasting and significant increase in the responses of the conditioned eye (response amplitude from conditioned eye, before: 2.89±0.25, after: 3.41±0.36, p=0.042; non-conditioned eye, before:
1.73±0.14, after: 1.80±0.16, p=0.845) and an increase in the ODI (ODI, before: 0.24±0.02, after: 0.30±0.02, p=0.018, n=11; Figure 2D and 2E). A subset of experimental mice failed to express Gs-DREADDs in V1; in these cases, the ODI did not change with conditioning (ODI, before: 0.26±0.11; after: 0.24±0.13, p=1, n=4). Altogether these results from the Gq-or Gs-DREADDs expressing mice support the idea that the direct activation of the GPCRs in V1 neurons is sufficient to drive the neuromodulation of ocular dominance plasticity.
Intracortical pathways modified by pairing monocular stimulation with neuromodulators and by monocular deprivation.
It was of interest to identify intracortical circuits within V1 affected by the neuromodulator pairing conditioning, and to compare them with the modifications induced by standard paradigms of experience dependent plasticity. Therefore, we evaluated in visual cortical slices the changes in postsynaptic strength induced by 1-hour conditioning in the presence of 5-HT2c agonist Ro 60-0175 and by 3 days of monocular deprivation (MD), as both manipulations result in a comparable decrease in the contralateral bias. The slices were prepared from the monocular V1 contralateral (MD, monocular deprived) or ipsilateral (ND, non-deprived) to the deprived eye in MD mice, and contralateral (C, conditioned) or ipsilateral (NC, non-conditioned) to the stimulated eye in mice conditioned with Ro 60-0175. Prior studies indicate that after p21 synaptic plasticity in V1 is restricted to non-granular layers, therefore we focused on inputs onto layer 2/3 pyramidal cells, specifically on the lateral inputs from other layer 2/3 cells and the ascending inputs from layer 4, both of which have been well studied in deprivation paradigms (Maffei and Turrigiano, 2008; Petrus et al., 2015) . The experiments were done in slices from mice that express channelrhodopsin-2 (ChR2) in layer 4 neurons (Petrus et al., 2015) , thus L4 inputs were stimulated optogenetically with blue light while L2/3 input were stimulated electrically ( Figure 3A ). For these two inputs we determined the quantal size (the postsynaptic response to the release of a single neurotransmitter vesicle) using the strontium (Sr 2+ ) to desynchronize the release of presynaptic neurotransmitter vesicles (Bekkers and Clements, 1999) . Under these conditions the average quantal size (the response evoked by a single vesicle) can be directly obtained from the isolated events recorded shortly after stimulation (400 ms windows, Figure 3B ), after correcting for spontaneous events occurring before the stimulation (Petrus et al., 2015; Tran et al., 2019 ; see methods for details). The results are reported in Figure   3 . Compared to cells from non-deprived (ND) hemisphere, in cells from deprived (MD) hemisphere the average amplitude of the computed evoked events is reduced in both L4 inputs (ND: 15.9±0.7 pA, n=7 mice, 10 cells; MD: 13.2±0.8 pA, n=6 mice, 12 cells, p=0.011; Figure   3C ) and L2/3 inputs (ND: 15.5±0.9 pA, n=5 mice, 9 cells; MD: 12.5±0.7 pA, n=6 mice, 8 cells, p=0.027; Figure 3D ). On the other hand, in the hemisphere conditioned (C) with monocular stimulation combined with injection of serotonergic agonist Ro 60-0175 the average amplitude of the events evoked by stimulating layer 4 inputs was severely reduced compared to the average in non-conditioned (NC) hemisphere (NC: 19.9±1.3 pA, n=5 mice, 8 cells; C: 14.2±1.0 pA, n=6 mice, 11 cells, p=0.002; Figure 3E ). In contrast, the average amplitude of the events evoked by layer 2/3 stimulation was not affected by the conditioning (NC: 16.5±1.4 pA, n=5 mice, 12 cells; C: 15.1±1.1 pA, n=6 mice, 11 cells, p=0.926; Figure 3F ). These results indicate that ascending excitatory inputs from layer 4 cells onto pyramidal cells in layer 2/3 are depressed by both type of conditioning. Lateral inputs, however, were significantly reduced only by MD, possibly because the neuromodulators conditioning was done under anesthesia (to minimize complications due to endogenous neuromodulatory tone), which would reduce the intracortical activity required for Hebbian plasticity. Nevertheless, the results are consistent with the idea that conditioning with neuromodulators act on pathways that are also affected by monocular deprivation.
Blockade of β-Adrenergic receptors during monocular deprivation induces paradoxical ocular dominance shift toward the visually deprived eye
According to the pull-push hypothesis of neuromodulation, the balance of the Gq/Gscoupled receptor signals determines the polarity of the synaptic plasticity. This balance can be shifted to favor LTP or LTD not only by agonists for specific GPCRs but can also be altered with antagonists. Previously we showed that the pharmacological blockade of β-adrenergic receptors is sufficient to bring an LTD-only state in slices, and also in vivo (Huang et al., 2012) . We asked therefore whether this intervention could also alter ocular dominance plasticity. We predicted that antagonizing β-adrenergic receptors during brief monocular deprivation (MD) would promote the depression of the responses to the most active eye: the non-deprived eye. This is exactly the opposite of the normal outcome of brief MD: depression of the derived eye. In these experiments we sutured one eyelid for 2 days in juvenile mice (P28-31) for 2 days, and at the same time we infused the bAR antagonist propranolol systemically with an osmotic pump (5 mg/kg/day, s.c.). The changes in cortical responsiveness were monitored in the hemisphere ipsilateral to the deprived eye to maximize detecting a depression of the non-deprived eye. Note that this arrangement is opposite to the one used in standard monocular deprivation studies that monitor the contralateral cortex. As shown in Figure 4B , in the vehicle control group the 2 days of MD increased the ODI (before: 0.24±0.01, after: 0.37±0.02, p=0.009, n=10), largely due to a reduction of in the response to the deprived eye (before: 1.98±0.11, after: 1.56±0.08, p=0.027), and without changes in responses to the non-deprived eye (before: 3.22±0.17, after: 3.44±0.22, p=0.275) ( Figure 4B ). In contrast, in the propranolol-treated group MD decreased the ODI (before: 0.24±0.01, after: 0.17±0.03, p=0.013, n=10) and reduced the responses to both the nondeprived eye (before: 2.85±0.17, after: 2.15±0.22, p=0.005) and the deprived eye (before:
1.74±0.10, after: 1.48±0.10, p=0.013). On other hand the propranolol treatment itself did not affect the ODI in non-deprived mice (before: 0.25±0.01, after: 0.26±0.03, p=0.800, n=9. Figure   4D ). The results indicate that manipulations that alter Gs/Gq-coupled signals can affect the outcome of MD in a manner predicted by the pull-push model. According to the model, the paradoxical shift in ocular dominance towards the deprived eye promoted by blocking Gscoupled β-adrenergic receptors will be the consequence of a predominance of Gq-coupled signaling favoring an LTD-only state in the cortex. In that scenario, the most active the inputs, the one from the non-deprived eye, will undergo more LTD.
Systemic administration of GPCR agonists in conjunction with brief monocular visual conditioning induces bidirectional change of ocular dominance after critical period
Experience dependent cortical plasticity diminishes as the animal mature (Heimel et al., 2007; Lehmann and Löwel, 2008; Pizzorusso et al., 2002; Sato and Stryker, 2008; Sawtell et al., 2003) . In juvenile mice MD induces depression of the responses evoked by the occluded eye and potentiation of responses to the open eye, but only during at the early stages of the critical period. MD does not depress the responses to the occluded eye in mice older than ~p35, and it does not potentiate the responses to the open eye in mice older than p90 (Lehmann and Löwel, 2008; Sato and Stryker, 2008; Sawtell et al., 2003) . It was of interest, therefore, to examine whether stimulation of GPCRs can promote bidirectional changes in ocular dominance after the end of the critical period. We first tested in adult mice (P130-140) the effects of monocular visual conditioning (1 hour) in conjunction with systemic injection of the a1 adrenergic agonist (coupled to Gq) methoxamine (15 mg/kg, i.p.), which effectively reduced ODI in juveniles (Supplementary Figure 1B) . Like in juveniles, in the adults the conditioning induced a robust and significant decrease in the ODI (ODI, before: 0.30±0.02, after: 0.15±0.03, p=0.003, n=9; Figure   5A ).
Next, we tried the complementary manipulation, to enhance the contralateral bias in adults by pairing the same visual conditioning with the b-adrenergic agonist (coupled to Gs) isoproterenol (15 mg/kg, i.p.). Unlike what we previously observed in juveniles (see Figure 1A ), the pairing with isoproterenol did not affect the ODI in adults (ODI, before: 0.31±0.02, after: 0.32±0.01, p=0.5, n=4; Figure 5B ). We reasoned that one factor that could have obscured the outcome is the age-dependent increase in the contralateral bias (Lehmann and Löwel, 2008) .
Indeed, in naïve adult mice (>P130) the ODI is significantly higher in the juvenile mice (p28~p35) and comparable to the ODI value in juveniles after monocular visual conditioning with isoproterenol (ODI, juvenile: 0.26±0.01, n=43; old: 0.30±0.01, n=18; juvenile after Iso: 0.35±0.01, n=9; F2,67 = 9.59, p=0.008; post hoc Holm-Šídák test p=0.029; Figure 5C ). These results suggest a ceiling effect. The contralateral bias of the visual response might be already saturated in adult mice, thus occluding further increases in ODI.
To overcome possible ceiling effects, we performed the isoproterenol-conditioning in mice subjected to long-term monocular deprivation (LTMD). This deprivation paradigm induces a profound reduction of the contralateral bias that is not fully reversed by reopening the deprived eye (He et al., 2007; Pizzorusso et al., 2006; Sale et al., 2007) . In these experiments we closed one eye at p21 and reopened it after p130. Cortical responses were imaged in the cortex contralateral to the deprived eye as shown in Figure 5D , first shortly after eye reopening and 3 days later, to assess spontaneous recovery. Then the conditioning with isoproterenol was performed and the responses were imaged again, and after a day in the dark to assess the stability of the induced changes. Mice subjected to LTMD exhibited a very low ODI (-0.04±0.02, n=14), compared to age matched naïve mice ( Figure 5C ). Seven mice that showed no signs of spontaneous recovery were conditioned with monocular visual conditioning paired with systemic isoproterenol, which resulted in an increased ODI ( Figure 5E , Before: -0.01±0.04; After: 0.11±0.05: p=0.031, n=7). In four of these mice we confirmed that the changes were maintained after one day in the dark (After1d: ODI: 0.11±0.04, n=4). Altogether the results indicate that the activation of Gs-and Gq-coupled receptors can promote experience-dependent bidirectional changes in ocular dominance in adults in accordance with the pull-push model, and long after the termination of the critical period.
DISCUSSION
Previously we proposed that the pull-push neuromodulation of Hebbian plasticity by the balance of Gs-and Gq-coupled receptors is a metaplasticity mechanism that allows rapid reconfiguration of the plastic state of cortical synapses over a wide range of possibilities, from LTP-only to LTD-only states (Huang et al., 2012) . Here we validated the pull-push model in vivo in V1 by demonstrating that manipulations of GPCR signals promote shifts in ocular dominance (Reiter and Stryker, 1988) . However, in our experiment, the badrenergic antagonist (propranolol) did not silence the cortical responses. We surmise that, in agreement with a previous study of us (Huang et al., 2012) , blocking β-adrenergic receptors was sufficient to shift the endogenous cortical Gs/Gq balance towards Gq enough to bring an LTDonly state. In that scenario, the most active inputs (from the open eye) will be reduced the most.
The complementary experiment, inducing an LTP-only state by blocking Gq-GPCRs was not attempted because different Gq-GPCRs, including cholinergic, adrenergic, serotonergic and glutamatergic receptors can substitute each other in enabling LTD (Choi et al., 2005) .
Consequently, achieving an LTP-only state would require the blockade of too many types of receptors, precluding a simple interpretation of the results. Finally, the cortical nature of the changes underlying the neuromodulators-induced ocular dominance shifts is supported by the ex vivo experiments showing that neuromodulator pairings and monocular deprivation do affects a common set of intracortical synapses. Moreover, in the chemogenetics approach to induce ocular dominance shifts, DREADD transfection was restricted to cortex, indicating that neuromodulation of cortical plasticity is sufficient to alter visual responses.
The crucial role of neuromodulators in experience-dependent plasticity in sensory cortices has been well recognized since the initial observations made by Kasamatsu and Pettigrew (1976, 1978) that in kittens the depletion of catecholamines prevent deprivationinduced ocular dominance shifts, and that superfusion of norepinephrine promote these changes even in adult cats (Heggelund et al., 1987; Kasamatsu, 1988, 1991) . Subsequent studies confirmed similar permissive roles for other neuromodulators, including acetylcholine and serotonin (Bear and Singer 1986; Gu and Singer, 1995) , and also extended these observations to rodent models and to other sensory cortices (Engineer et al., 2013; Golovin and Ward, 2016; Kang et al., 2014; Meunier et al., 2017; Shepard et al., 2015; Weinberger, 2015) .
The prevailing interpretation emerging from these studies is that neuromodulators gate cortical plasticity by enhancing sensory perception, and by promoting patterns of cortical activity suitable for plasticity induction via controlling network excitability. This is consistent with a wealth of studies documenting that neuromodulators improve perception in vivo (see Gelbard-Sagiv et al., 2018; Jacob and Nienborg, 2018; McBurney-Lin et al., 2019; Nadim and Bucher, 2014 for reviews) also affect cellular intrinsic excitability and synaptic inhibition to gate the induction of Hebbian plasticity in vitro (see Brzosko et al., 2019; Palacios-Filardo and Mellor, 2019; Pawlak et al., 2010 for reviews) . We propose an additional and different mode of action: direct control of the expression, not the induction, of Hebbian plasticity via the Gq/Gs based pull-push metaplasticity mechanism that we previously demonstrated in vitro, in slices. The exact contribution of these three distinct types of neuromodulation to naturally occurring plasticity remains to be determined. This is a challenging task considering that the neuromodulatory systems can interact between them, can substitute each other in promoting plasticity (Bear and Singer, 1986) , and can stimulate multiple GPCRs, often with opposite actions. One clear example is the case of adrenergic receptors, where the a1and the badrenoreceptors can promote respectively depression or potentiation of the same activated inputs (Figure 1 and Supplementary Figure 2) .
The demonstration that the pull-push metaplasticity is operational in vivo has consequences beyond deepening our understanding of how neuromodulators shape cortical plasticity. Pairing monocular stimulation with GPCR agonists could be developed as a tool to bidirectionally manipulate the strength of targeted cortical circuits in a rapid and controlled manner. The neuromodulator pairing elicit stable changes in cortical response comparable in magnitude with those induced by classical deprivation paradigms like MD, but on a faster time scale: hours instead of days (Lehmann and Löwel, 2008) . Importantly, the neuromodulator approach readily works in post-critical period adults, at an age when the deleterious effects of long-term monocular deprivation, an established animal model of amblyopia, cannot be reversed by simple manipulation of visual experience. Several other non-invasive manipulations have been reported to enhance adult cortical plasticity after the critical period, but through other mechanisms. For example, dark exposure (He et al., 2007) , environmental enrichment (Sale et al., 2007) , antidepressant treatments (Maya Vetencourt et al., 2008) , locomotion (Kaneko et al., 2017) , and retinal inactivation (Duffy et al., 2018) , are thought to rejuvenate cortical plasticity by decreasing the intracortical inhibition, while cross-modal deprivation is thought to reactivate thalamocortical plasticity (Rodríguez et al., 2018; Teichert et al., 2019) . It would be of therapeutical interest to explore complementary synergies between these manipulations and the neuromodulatory pairings in the recovery from long-term monocular deprivation. 
MATERIALS AND METHODS

Animals
C57BL/6J (Jackson Laboratory, Bar Harbor, ME) mice, Cre dependent Gs-DREADD (ROSA26-LSL-GsDREADD-CRE-luc) (Akhmedov et al., 2017;  generously gifted from Rebecca Berdeaux) mice, and layer 4 specific ChR2 expressing mice (F1 between Scnn1a-cre x Ai32(RCL-ChR2(H134R)/EYFP); Jackson Laboratory) were reared in a 12 hours light/dark cycle. Juvenile mice (P28-35) or fully-grown adult mice (>P130) of both sexes were used. All protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at Johns Hopkins University and followed the guidelines established by the Animal Care Act and National Institutes of Health (NIH). Only black Cre dependent Gs-DREADD mice were used for the experiments.
Optical imaging of the intrinsic signal
Mice were anesthetized with isoflurane (2-3% for induction; 0.7-1.2% for maintenance in oxygen) supplemented with chlorprothixene (2 mg/kg, i.p.) and placed with head-fixed in front of the LCD monitor for visual stimulus. Atropine was injected subcutaneously to reduce mucosal secretion (0.05 mg/kg). Eye drops were administered to keep eyes moist and body temperature was maintained at 37˚C with heating pad and rectal probe. Heart rate was monitored throughout the experiment by electrocardiogram. The skull over the V1 region on the left hemisphere was exposed and washed with hydrogen peroxide. Agarose (3%) and an 8 mm round glass coverslip were placed on top of the exposed area. Optical imaging was performed following the method optimized for the measure of the ocular dominance in mice (Cang et al., 2005; Kalatsky and Stryker, 2003) . Briefly, visual response intrinsic signals were acquired using a Dalsa 1M30 CCD camera (Dalsa, Waterloo, Canada) controlled by custom software. The surface vasculature and intrinsic signals were visualized with LED illumination (555-nm and 610-nm, respectively). The camera was focused 600 mm below from the surface of the skull. An additional red filter was interposed to the CCD camera and intrinsic signal images were acquired. A high refresh rate monitor (1024x768 @ 120 Hz; ViewSonic, Brea, CA) was placed 25-cm in front of the mouse, with their midline aligned to the midline of the mouse for visual stimulus. The visual stimulus presented was restricted to the binocular visual field (-5˚ to +15˚ azimuth) and consisted of a horizontal thin bar (height = 2˚, width = 20˚) continuously presented for 5 minutes in upward (90 ) and downward (270˚) directions to each eye separately. The cortical response at the stimulus frequency was extracted by Fourier analysis and the two maps generated with the opposite direction of drifting bar were averaged for each eye to calculate the response amplitude as well as the ocular dominance index (ODI). The ODI was computed as following: (1) the intensity maps were smoothed by 5x5 low-pass Gausian filter; (2) the binocular region of interest (ROI) was defined at 30% of peak response amplitude of the smoothed intensity map from the ipsilateral eye; (3) the response amplitude of each eye were calculated by averaging the intensity of all pixels in the ROI; (4) the ODI was calculated by the average of (C-I)/(C+I) of all pixels in the ROI where C and I are the contralateral (C) and ipsilateral (I) eye respectively.
Monocular visual conditioning
Mice were anesthetized and maintained with isoflurane (2-3% for induction; 1.0-1.5% for maintenance in oxygen) so that the heart rate to be 480-570/min throughout the conditioning session and placed with head-fixed in front of the LCD monitor. Right eye of mice was exposed to visual stimulation consists of black and white drifting gratings phase-reversing at 1 Hz and rotated with step increments of multiples of 22.5˚/min (width 3.72˚; length 71˚; contrast 100%) generated with Matlab (Mathworks, Natick, MA). Visual stimulus was presented in a randomized fashion and lasted for an hour. Neuromodulator agonist or vehicle was injected intraperitoneally 30 min in advance from the start of the visual conditioning. To prevent the abrupt increase of the heart rate by isoproterenol administration, nadolol (5 mg/kg, i.p.) was preadministrated 20 min before the isoproterenol injection. After the conditioning session, the mouse was kept in a dark environment until being used for the next imaging session.
Monocular deprivation
Short-term monocular deprivation of juvenile mice (P28-31) in figure 4 was done by closing the left eye (ipsilateral from the imaging hemisphere). Long-term monocular deprivation in figure 5 was done by closing the right eye (contralateral from the imaging hemisphere) of mice at p21. After the mice anesthetized with isoflurane (2-3% for induction; 1.5% for maintenance), the margins of upper and lower eye lids were trimmed and sutured shut. Small amount of Neosporin was applied to the sutured eye to prevent an infection. The sutured eye was checked before it was opened for an imaging session to make sure the integrity of the lid suture.
Osmotic pump drug infusion
Mice receiving subcutaneous drug infusion were implanted with osmotic pumps (Alzet 1007D, DURECT Corporation, Cupertino, CA). The pumps were primed in saline at 37˚C. To implant the osmotic pump, mice were anesthetized with isoflurane (2-3% for induction; 1.5% for maintenance) and the pump was installed subcutaneously. Meloxicam (5 mg/kg, s.c.) was administered after the surgery as an analgesic.
Slice electrophysiology Preparation of cortical slices
Brain slices from mice (9-12 weeks) were prepared as described previously with some modifications (Huang et al., 2012) . Briefly, each mouse was anesthetized using isoflurane vapors, then transcardially perfused with ice cold dissection buffer (dissection buffer in mM: 212.7 sucrose, 5 KCl, 1.25 NaH2PO4, 10 MgCl2, 0.5 CaCl2, 26 NaHCO3, and 10 dextrose bubbled with 95%O2/5% CO2 (pH 7.4)) and immediately decapitated. The brain was removed and immersed in the ice-cold dissection buffer. Thin (300 µm) coronal slices of visual cortex were cut in the ice-cold dissection buffer and transferred to a light-tight holding chamber with artificial cerebrospinal fluid (ACSF in mM: 119 NaCl, 5 KCl, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, and 10 dextrose bubbled with 95%O2/5% CO2 (pH 7.4)). The slices were incubated at 30˚C for 30 minutes and then kept at room temperature until they were transferred to recording chamber.
Whole-cell current clamp recordings for LTP and LTD
Whole-cell current clamp recordings were performed using C57BL/6J mice. Recordings were made from layer 2/3 pyramidal neurons in the V1 with glass pipettes (3-5 Mohm) filled with potassium based internal solution (internal solution in mM: 130 K-gluconate, 10 KCl, 0.2 EGTA, 10 HEPES, 4 Mg-ATP, 0.5 Na-GTP, and 10 Na-phosphocreatine (pH 7.2-7.3, 280-290 mOsm). Excitatory postsynaptic potentials (EPSPs) were evoked every 20 seconds by two concentric bipolar electrodes (125 mm diameter; FHC, Bowdoin, ME) placed ~0.9 mm apart in the middle of the cortical thickness. Stimulus intensity was adjusted to evoke simple waveform (2-10 mV), short onset latency (<4 ms) monosynaptic EPSPs. Synaptic strength was quantified by measuring the initial slope (the first 2 ms) of EPSPs and input independence was confirmed by the absence of paired-pulse interactions. Mean baseline slope was calculated from 30 consecutive sweeps before the start of CNO (10 µM) application. After 10 minutes from the perfusion of CNO, Spike-timing dependent plasticity (STDP) was induced by 200 pairings consist of one presynaptic activation given either 10 ms before or 10 ms after four consecutive action potentials (100 Hz) evoked by supra-threshold depolarizing current steps through the recording electrode (~1 nA, 2 ms). After the induction of STDP, CNO was washed out with normal ACSF and the EPSPs were recorded for at least 30 minutes afterward.
Whole-cell voltage clamp recordings for pathway specific Sr 2+ desyncronized EPSCs
Whole-cell voltage clamp recordings were performed using the layer 4 specific ChR2 expressing mice. Slices were pre-incubated with Ca 2+ -free ACSF containing 4 mM Sr 2+ and 4 mM Mg 2+ (95% O2/5% CO2) for 20 minutes before the initiation of the recordings. To record AMPA receptor mediated desyncronized EPSCs, the recordings were done in the presence of 20 µM bicuculline and 100 µM DL-2-amino-5 phosphonopentanoic acid (DL-APV). Recording pipettes were filled with internal solution containing (in mM): 130 Cs-gluconate, 8 KCl, 1 EGTA, 10 HEPES, 4 ATP, and 5 QX-314, pH 7.4, 285-295 mOsm. Visually identified layer 2/3 pyramidal neurons were voltage clamped at -80 mV. Desyncronized EPSCs were elicited by activating ChR2 from the layer 4 projections or by stimulating lateral projections with stimulating electrode. ChR2 was activated using 470 nm or white LED illuminated through a 40X objective lens. To stimulate lateral projections, a theta glass stimulating electrode was positioned laterally away about 100-200 µm from the recorded neuron. The minimal intensity of light (5 ms duration) or electrical stimulation (0.2 ms duration) was determined to elicit a reliable response on a cell-by-cell basis. Current sweeps were acquired every 10 s for a duration of 1500 ms including a 5 mV test pulse (100 ms duration). A light or electrical stimulation was evoked at 700 ms from the start of each sweep, and a 400 ms window before stimulation was used for quantifying spontaneous desynchronized EPSC events (preStim) and a 400 ms window after a 50ms delay from stimulation onset was used for quantifying stimulation-evoked desynchronized events (postStim). The desyncronized EPSC event analysis was performed using Mini Analysis software (Synaptosoft, Decatur, GA) with threshold set to 3 times the root mean square (RMS) noise. Events with rise time > 3 ms and cells with an RMS noise > 2 were excluded. To calculate the average amplitude of the evoked Sr 2+ desyncronized EPSC events without spontaneous events, following equation was used: [(postStim amp x postStim freq) -(preStim amp x preStim freq)] / (postStim freq -preStim freq) where amp is amplitude and freq is frequency.
Viral injection
Adeno-associated virus expressing Gq-or Gs-coupled DREADD under the control of the Ca2+/calmodulin-dependent protein kinase II (CamKII) promoter was injected to the V1 region of 3 weeks old mice bilaterally (Gq-coupled DREADD: AAV2-CamKIIa-HA-rm3D(Gq)-IRES-mCitrine; Gs-coupled DREADD: AAV8-CamKIIa-HA-rm3D(Gs)-IRES-mCitrine; from UNC Vector Core, Chapel Hill, NC). C57BL/6J mice of either sex were anesthetized and head fixed in a stereotaxic device (Kopf Instruments, Los Angeles, CA) under 1.5%-2% isoflurane. The superficial layer of the V1 was targeted with following coordinate: bregma -3.6, lateral 2.5, depth 0.3. AAVs (800 nl) were injected with syringe infusion pump. After the injection, mice were recovered on a heat pad and were returned to their home cage once they awake. Viral injection of the recombinant adeno-associated virus expressing Cre recombinase under the control of human synapsin promoter (rAAV-hSyn-Cre; from SignaGen Laboratories, Rockville, MD) was done by bulk regional viral injection to the visual cortical area of neonatal Cre dependent Gs-DREADD mice at p1. Briefly, neonatal mice were cryo-anesthetized (Phifer and Terry, 1986) in an ice-cold chamber and positioned dorsal side up secured with an adhesive bandage across the upper body. The visual cortical area was guided with anatomical landmarks, including occipital fontanelle and lambdoid suture, which are visible through the neonatal skin. 50 nl of rAAVs were injected right beneath the skull slowly with syringe infusion pump (5 nl/sec). After the injection, the mice were kept on a heat pad for the recovery and returned to their home cage once awake.
Immunohistochemistry
The expression of Gs-DREADDs in the V1 was examined by visualizing the GFP expression conjugated to the DREADDs at the end of the optical imaging experiments. The GFP signal from these mice were hardly detectable, so the GFP fluorescence signal was magnified with fluorochrome conjugated antibody. The anesthetized mice were transcardially perfused with 10% neutral buffered formalin solution. Following perfusion, the brain was extracted and kept in the fixative solution overnight. The brain was sliced into 70 µm coronal sections and the slices were transferred to phosphate buffered saline (PBS). The slices were permeabilized in 0.2% Triton-X 100 in PBS solution for an hour, blocked in a 5% normal goat serum for an hour, and washed in PBS. The slices were then treated overnight at 4˚C with chicken anti-GFP antibody (1:2000) (Aves Labs, Inc., Davis, CA). Then the slices were washed in PBS and treated with Alexa 488 conjugated goat anti-chicken IgY antibody (1:400) (Abcam, Cambridge, UK) for 2 hours. The slices were washed in PBS for an hour and mounted on a slide glass. Slides were coverslipped with the Prolong Gold anti-fade mounting solution with DAPI (Cell Signaling Technology, Inc., Danvers, MA) incorporated.
Drug administration
Isoproterenol (Tocris Bioscience, Bristol, UK), Ro 60-0175 (Tocris), propranolol (Sigma-Aldrich, St. Louis, MO), nadolol (Sigma-Aldrich) and methoxamine (Sigma-Aldrich) were prepared in saline. CNO (Enzo Life Sciences, Farmingdale, NY) was dissolved in 5% DMSO and 95% saline.
Statistical analysis
For two sample comparisons we used Matlab to perform the Wilcoxon signed-rank test, in the case of paired samples, and the Wilcoxon rank sum, in the case of non-paired samples. For comparison of multiple groups, we used Prism (GraphPad Software, San Diego, CA) first to confirm the normal distribution of each group with the Shapiro-Wilk test. Then we performed a one-way ANOVA followed by Holm-Sidak post hoc test. Data are presented as averages ± s.e.m. 
